The Application of Artificial Intelligence to Microarray Data: Identification of a Novel Gene Signature to Identify Bladder Cancer Progression
Authors:
- James W.F. CattoJCJames W.F. Catto
- Maysam F. AbbodMAMaysam F. Abbod
- Peter J. WildPWPeter J. Wild
- Derek A. LinkensDLDerek A. Linkens
- Christian PilarskyCPChristian Pilarsky
- Ishtiaq RehmanIRIshtiaq Rehman
- Derek J. RosarioDRDerek J. Rosario
- Stefan DenzingerSDStefan Denzinger
- Maximilian BurgerMBMaximilian Burger
- Robert StoehrRSRobert Stoehr
- Ruth KnuechelRKRuth Knuechel
- Arndt HartmannAHArndt Hartmann
- 1 March 2010
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 57 (3) , 398-406
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment StrategyEuropean Urology, 2009
- A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networksBreast Cancer Research and Treatment, 2009
- Application of Artificial Intelligence to the Management of Urological CancerJournal of Urology, 2007
- Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation StudyClinical Cancer Research, 2007
- Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and ReportingJNCI: Journal of the National Cancer Institute, 2007
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Less is more: artificial intelligence and gene-expression arraysThe Lancet, 2004
- Rules of evidence for cancer molecular-marker discovery and validationNature Reviews Cancer, 2004
- Identifying distinct classes of bladder carcinoma using microarraysNature Genetics, 2002
- Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networksNature Medicine, 2001